Vitamin B6 Pms Randomized Trial: What the Evidence Says

Quick Answer

Vitamin B6 Pms Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 randomized trial, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Moreover, taking such drugs during Ramadan has been reported to increase the risk of cerebral venous thrombosis, and psychological resistance remains a major global challenge. [Iimura Jun (2026); evidence level 2]
• For instance, Ahmadi reported that zinc supplementation reduced PMD symptoms, and Tartagni reported the same for vitamin D. [Iimura Jun (2026); evidence level 2]
• Some evidence suggests that women with Rh-negative blood type may have a higher likelihood of developing premenstrual symptoms, although mechanistic explanations remain speculative and findings are not yet consistent across studies. [Martire Francesco Giuseppe (2026); evidence level 4]
• High caffeine intake has also been linked to increased PMS risk, possibly through its impact on sleep quality, anxiety, and neuroendocrine regulation. [Martire Francesco Giuseppe (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For vitamin b6 pms randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Iimura Jun (2026). Novel dietary FemTech based on dietary reference intakes for premenstrual and menstrual disorders: a pilot open-label randomized controlled trial of dietary intervention. DOI: 10.1186/s12905-026-04382-6. PMCID: PMC13019880. PMID: 41803877. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13019880/
• Martire Francesco Giuseppe (2026). Premenstrual Syndrome and Nutritional Factors: A Narrative Review of Current Evidence and Clinical Implications. DOI: 10.3390/jcm15031124. PMCID: PMC12898590. PMID: 41682804. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12898590/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.